Corrigendum: Akkermansia muciniphila suppressing nonalcoholic steatohepatitis associated tumorigenesis through CXCR6+ natural killer T cells

Tao Li; Xinlong Lin; Binhai Shen; Wujian Zhang; Yangyang Liu; Hongbin Liu; Ye Wang; Lijun Zheng; Fachao Zhi

doi:10.3389/fimmu.2023.1297103

Corrigendum: Akkermansia muciniphila suppressing nonalcoholic steatohepatitis associated tumorigenesis through CXCR6⁺ natural killer T cells

Front Immunol. 2023 Nov 27:14:1297103. doi: 10.3389/fimmu.2023.1297103. eCollection 2023.

Authors

Tao Li¹, Xinlong Lin¹, Binhai Shen¹, Wujian Zhang², Yangyang Liu³, Hongbin Liu¹, Ye Wang³, Lijun Zheng³, Fachao Zhi¹

Affiliations

¹ Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.
² Department of General Surgery of the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Haerbin, China.
³ Guangzhou ZhiYi Biotechnology Co. Ltd., Guangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.1047570.].

Keywords: Akkermansia muciniphila; cancer progression; hepatocellular carcinoma - metabolic syndrome - non-alcoholic fatty liver disease (NAFLD) - non-alcoholic steatohepatitis - NASH-HCC; nonalcoholic fatty liver disease; tumor immune surveillance.

Publication types

Published Erratum